Predicting responsiveness to fampridine in gait-impaired patients with multiple sclerosis

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
L FilliM Linnebank

Abstract

Fampridine leads to significant improvements in walking in many people with multiple sclerosis (PwMS). However, a relevant proportion of PwMS does not respond to fampridine and predictors of initial drug responsiveness are unknown. Drug response to prolonged-release (PR)-fampridine was assessed in 55 PwMS using the timed 25-foot walk (T25FW), 6-min walk test (6MWT) and 12-item multiple sclerosis walking scale as outcome parameters. Patients were treated with PR-fampridine and placebo for 6 weeks each in a randomized, double-blind, placebo-controlled trial with crossover design (NCT01576354). Possible predictors of drug responsiveness were investigated by multiple correlation analysis and binary logistic regression models. An additional longitudinal analysis followed the drug responses of 32 patients treated with PR-fampridine over 3 years to identify potential predictors of long-term drug responsiveness. Severity of walking disability was positively correlated with enhanced responses to PR-fampridine. The strongest single predictor of drug responsiveness was poor 6MWT performance at baseline, which was positively correlated with enhanced drug response in the 6MWT (R = -0.541; P < 0.001). A multivariable logistic regression mode...Continue Reading

References

Oct 20, 2000·Medicine and Science in Sports and Exercise·K J Finn, B Specker
Jan 3, 2001·Neurology·S R Schwid New York State Multiple Sclero
Oct 19, 2007·Multiple Sclerosis : Clinical and Laboratory Research·Myla D GoldmanJeffrey A Cohen
Mar 3, 2009·Lancet·Andrew D GoodmanUNKNOWN Fampridine MS-F203 Investigators
Jan 21, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Lisa M L van WinsenBernard M J Uitdehaag
Oct 27, 2010·Annals of Neurology·Andrew D GoodmanUNKNOWN MSF204 Investigators
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·Myla D GoldmanRichard A Rudick
Sep 29, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Domien GijbelsPeter Feys
Feb 22, 2013·Neurology·Ilya KisterJoseph Herbert
Jun 4, 2013·Multiple Sclerosis : Clinical and Laboratory Research·J B RaffelR S Nicholas
Dec 21, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·D ZellerM Buttmann
Apr 1, 2011·International Journal of MS Care·Francois Bethoux, Susan Bennett
May 24, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Hb JensenE Stenager
Oct 23, 2014·International Journal of MS Care·Andrew D GoodmanAndrew R Blight
Apr 30, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Raymond HuppertsJacob Elkins
Jan 15, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Björn ZörnerMichael Linnebank
Jul 4, 2016·NeuroRehabilitation·Yara Dadalti FragosoThereza Cristina Winckler
Jan 6, 2017·The International Journal of Neuroscience·Miriam Alvarez-PayeroLuciana Midaglia
Jul 26, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Francisco Alejandro Rodriguez-LealTjalf Ziemssen

❮ Previous
Next ❯

Citations

Jul 31, 2020·Expert Review of Neurotherapeutics·Bernardita SolerPeter Feys
Apr 27, 2021·Expert Opinion on Pharmacotherapy·Alice BaronciniFilippo Migliorini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.